Magnetic Resonance Imaging (MRI) Using Liverspecific Oral Contrast Agent in Metastatic Colorectal Cancer Patients

This study is currently recruiting participants.

Verified by Copenhagen University Hospital at Herlev, September 2006

Sponsored by:	Copenhagen University Hospital at Herlev
Information provided by:	Copenhagen University Hospital at Herlev
ClinicalTrials.gov Identifier:	NCT00718055

Purpose

The purpose of this study is to determine whether MRI with manganese containing contrast agent detects more livermetastasis compared to CT scan

Condition	Phase
Neoplasm Metastasis Liver Colorectal Neoplasms Magnetic Resonance Imaging Contrast Media	Phase IV

MedlinePlus related topics: Cancer Colorectal Cancer MRI Scans

Study Type:	Observational
Study Design:	Cohort, Prospective
Official Title:	MR Skanning Med Leverspecifikt Oralt Kontraststof Sammenlignet Med CT Skanning Hos Colorectalcancer Patienter Med Levermetastaser

Further study details as provided by Copenhagen University Hospital at Herlev:

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	50
Study Start Date:	November 2006

Eligibility

Study Population

consekutive group of liver metastatic patients

Criteria

Inclusion Criteria:

Exclusion Criteria:

pacemaker, metal in the body, claustrophobia, pregnancy, age below 18 years, psychiatry patients

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00718055

Contacts

Contact: Vibeke Løgager, M.D	44883996
Contact: Jakob M Møller, M.Sc	44883996	jaml@herlevhosp.dk

Locations

Denmark
Copenhagen Uni. Hospital at Herlev dept. of Radiology	Recruiting
Herlev, Denmark, 2730
Contact: Vibeke Løgager, M.D
Contact: Jakob M Møller, M.Sc 44883996 jaml@herlevhosp.dk

Sponsors and Collaborators

Copenhagen University Hospital at Herlev

Investigators

Principal Investigator:

Vibeke Løgager, M.D.

Copenhagen University Hospital at Herlev

More Information

Responsible Party:	Herlev Hospital ( Vibeke Løgager )
Study ID Numbers:	KA-20060096
Study First Received:	October 4, 2006
Last Updated:	July 17, 2008
ClinicalTrials.gov Identifier:	NCT00718055
Health Authority:	Denmark: Danish Medicines Agency

Keywords provided by Copenhagen University Hospital at Herlev:

MRI
liverspecific
contrast
colorectal
metastases

Study placed in the following topic categories:

Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Colonic Diseases
Neoplasm Metastasis

Gastrointestinal Neoplasms
Intestinal Diseases
Rectal Diseases
Intestinal Neoplasms
Colorectal Neoplasms

Additional relevant MeSH terms:

Neoplastic Processes
Neoplasms
Pathologic Processes
Neoplasms by Site

ClinicalTrials.gov processed this record on January 13, 2009